tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsPositive Outlook for Contineum Therapeutics Amidst Minor Trial Delays
2M ago
Contineum completes enrollment for cohorts of PIPE-791 trial
Premium
The Fly
Contineum completes enrollment for cohorts of PIPE-791 trial
2M ago
Premium
Ratings
Positive Outlook on Contineum Therapeutics: Promising Pipeline and Strategic Collaborations Drive Buy Rating
2M ago
Contineum files $300M mixed securities shelf
PremiumThe FlyContineum files $300M mixed securities shelf
4M ago
Premium
Pre-Earnings
Contineum Therapeutics, Inc. Class A (CTNM) Q1 Earnings Cheat Sheet
4M ago
Contineum names Timothy Watkins as Chief Medical Officer
Premium
The Fly
Contineum names Timothy Watkins as Chief Medical Officer
4M ago
PremiumCompany AnnouncementsContineum Therapeutics: Financial Results and Clinical Milestones
6M ago
Contineum assumed with an Overweight at Morgan Stanley
Premium
The Fly
Contineum assumed with an Overweight at Morgan Stanley
6M ago
Contineum price target lowered to $16 from $32 at Baird
Premium
The Fly
Contineum price target lowered to $16 from $32 at Baird
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100